Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

NAFLD and NASH in Postmenopausal Women: Implications for Diagnosis and Treatment
Johanna K. DiStefano
Endocrinology (2020) Vol. 161, Iss. 10
Open Access | Times Cited: 163

Showing 1-25 of 163 citing articles:

The 2022 hormone therapy position statement of The North American Menopause Society
Stephanie S. Faubion, Carolyn Crandall, Lori A. Davis, et al.
Menopause The Journal of The North American Menopause Society (2022) Vol. 29, Iss. 7, pp. 767-794
Closed Access | Times Cited: 436
Emerging therapeutic approaches for the treatment of NAFLD and type 2 diabetes mellitus
Daniel Ferguson, Brian N. Finck
Nature Reviews Endocrinology (2021) Vol. 17, Iss. 8, pp. 484-495
Open Access | Times Cited: 338
Safety of Fezolinetant for Vasomotor Symptoms Associated With Menopause
Genevieve Neal-Perry, Antonio Cano, Samuel Lederman, et al.
Obstetrics and Gynecology (2023)
Open Access | Times Cited: 61
Global prevalence of nonalcoholic fatty liver disease: an updated meta-analysis on 78 million population over 38 countries
Ehsan Amini‐Salehi, Negin Letafatkar, Naeim Norouzi, et al.
Archives of Medical Research (2024) Vol. 55, Iss. 6, pp. 103043-103043
Closed Access | Times Cited: 35
Prevalence of at‐risk MASH, MetALD and alcohol‐associated steatotic liver disease in the general population
Carolin V. Schneider, Kai Markus Schneider, A. Raptis, et al.
Alimentary Pharmacology & Therapeutics (2024) Vol. 59, Iss. 10, pp. 1271-1281
Closed Access | Times Cited: 23
The Role and Mechanism of Oxidative Stress and Nuclear Receptors in the Development of NAFLD
Ting Hong, Yiyan Chen, M Kellis, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 69
Perspectives on Precision Medicine Approaches to NAFLD Diagnosis and Management
Amedeo Lonardo, Juan Pablo Arab, Marco Arrese
Advances in Therapy (2021) Vol. 38, Iss. 5, pp. 2130-2158
Open Access | Times Cited: 67
Beyond the X Factor: Relevance of Sex Hormones in NAFLD Pathophysiology
Sara Della Torre
Cells (2021) Vol. 10, Iss. 9, pp. 2502-2502
Open Access | Times Cited: 56
Metabolic mechanisms for and treatment of NAFLD or NASH occurring after liver transplantation
Amedeo Lonardo, Alessandro Mantovani, Salvatore Petta, et al.
Nature Reviews Endocrinology (2022) Vol. 18, Iss. 10, pp. 638-650
Closed Access | Times Cited: 44
Risk of advanced fibrosis in first-degree relatives of patients with nonalcoholic fatty liver disease
Nobuharu Tamaki, Noora Ahlholm, Panu K. Luukkonen, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 21
Open Access | Times Cited: 42
NAFLD in normal weight individuals
Johanna K. DiStefano, Glenn S. Gerhard
Diabetology & Metabolic Syndrome (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 41
The role of microbiomes in gastrointestinal cancers: new insights
Aref Yarahmadi, Hamed Afkhami
Frontiers in Oncology (2024) Vol. 13
Open Access | Times Cited: 12
Weight Gain in Midlife Women
Maria D. Hurtado, Mariam Saadedine, Ekta Kapoor, et al.
Current Obesity Reports (2024) Vol. 13, Iss. 2, pp. 352-363
Open Access | Times Cited: 10
Menopause and metabolic dysfunction-associated steatotic liver disease
Stergios A. Pοlyzos, Dimitrios G. Goulis
Maturitas (2024) Vol. 186, pp. 108024-108024
Closed Access | Times Cited: 10
Letter: Lubiprostone Treatment for MASLD—Gender Imbalance and Blinding Considerations
J.Z. Li, Qi‐En Shen
Alimentary Pharmacology & Therapeutics (2025)
Closed Access | Times Cited: 1
Non-Alcoholic Steatohepatitis (NASH) and Organokines: What Is Now and What Will Be in the Future
João Paulo Margiotti dos Santos, Mariana Canevari de Maio, Monike Alves Lemes, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 1, pp. 498-498
Open Access | Times Cited: 38
Non-alcoholic fatty liver disease prevalence in Latin America: A systematic review and meta-analysis
Yesmi Arcelia Ortega Rojas, Claudia L. Vidal-Cuéllar, Karina Mercedes Aparicio Barrón, et al.
Annals of Hepatology (2022) Vol. 27, Iss. 6, pp. 100706-100706
Open Access | Times Cited: 36
Interplay Between GH-regulated, Sex-biased Liver Transcriptome and Hepatic Zonation Revealed by Single-Nucleus RNA Sequencing
Christine N. Goldfarb, Kritika Karri, Maxim Pyatkov, et al.
Endocrinology (2022) Vol. 163, Iss. 7
Open Access | Times Cited: 33
Microbial endocrinology: the mechanisms by which the microbiota influences host sex steroids
Sophie Cotton, Charlotte A. Clayton, Carolina Tropini
Trends in Microbiology (2023) Vol. 31, Iss. 11, pp. 1131-1142
Closed Access | Times Cited: 21
Association of serum uric acid-to-high-density lipoprotein cholesterol ratio with non-alcoholic fatty liver disease in American adults: a population-based analysis
Yilian Xie, Kai Huang, Xiangyu Zhang, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 20
Hormonal regulation of metabolism—recent lessons learned from insulin and estrogen
Zhipeng Tao, Zhiyong Cheng
Clinical Science (2023) Vol. 137, Iss. 6, pp. 415-434
Open Access | Times Cited: 17
Sex differences in mortality and liver‐related events in non‐alcoholic fatty liver disease: A systematic review and meta‐analysis
Huimin Zhou, Haiyan Chen, Hanxiao Lu, et al.
Liver International (2024) Vol. 44, Iss. 7, pp. 1600-1609
Closed Access | Times Cited: 8
Mid-term Effects of Bariatric Surgery on Metabolic Dysfunction-Associated Fatty Liver Disease Remission and Predictive Factors: A Prospective Study with a Focus on Non-invasive Diagnosis
Èlia Navarro‐Masip, Núria Mestres Petit, Marta Zorzano-Martínez, et al.
Obesity Surgery (2024) Vol. 34, Iss. 3, pp. 841-849
Closed Access | Times Cited: 7
Weight loss response to semaglutide in postmenopausal women with and without hormone therapy use
Maria D. Hurtado, Elif Tama, Sima Fansa, et al.
Menopause The Journal of The North American Menopause Society (2024) Vol. 31, Iss. 4, pp. 266-274
Open Access | Times Cited: 7
Targeting nuclear receptors for NASH/MASH: From bench to bedside
Rohit A. Sinha
Liver Research (2024) Vol. 8, Iss. 1, pp. 34-45
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top